首页> 外文期刊>Current opinion in urology >Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection
【24h】

Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection

机译:腹腔镜和机器人化疗后腹膜后淋巴结清扫术

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose Of review: Open surgical postchemotherapy retroperitoneal lymph node dissection remains the standard of care. On the contrary, laparoscopy is an emerging technique and reports of laparoscopic lymph node dissection postchemotherapy are increasing. Our purpose is to present indications, technique and outcomes of laparoscopic postchemo retroperitoneal lymph node dissection. Recent findings: With growing expertise and knowledge the morbidity of the laparoscopic approach is much reduced compared with open surgery with the same oncological outcome. Robotic surgery is a more recent approach with growing usage in urology. However, no reports of robotic postchemotherapy lymph node dissection are available. Summary: In expert hands laparoscopic lymph node dissection is a feasible technique, offering less morbidity to patients with good oncological results.
机译:审查目的:开放式化疗后腹膜后淋巴结清扫术仍然是治疗的标准。相反,腹腔镜是一种新兴技术,化学疗法后腹腔镜淋巴结清扫术的报道越来越多。我们的目的是介绍腹腔镜化疗后腹膜后淋巴结清扫术的适应症,技术和结果。最新发现:随着专业知识和知识的不断增长,与具有相同肿瘤学结局的开放手术相比,腹腔镜手术的发病率大大降低。机器人手术是一种新近的方法,在泌尿外科领域的使用越来越多。但是,尚无关于机器人化疗后淋巴结清扫的报道。简介:在专家的手腹腔镜淋巴结清扫术是一种可行的技术,为具有良好肿瘤学结果的患者提供较低的发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号